{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:29:20Z","timestamp":1782080960585,"version":"3.54.5"},"reference-count":6,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":1394,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2002,4]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> The aim of this study was to estimate the possibility of predicting the course of type 1 diabetes. We analyzed the importance of islet cell antibody levels and residual \u03b2 cell function in 46 newly diagnosed patients with diabetes. Islet cell antibodies (ICAs; Juvenile Diabetes Foundation [JDF] units) were determined at the time of diagnosis by the indirect immunofluorescent method. \u03b2 cell function was estimated by C peptide levels (nmol\/L) before and after glucagon stimulation at the time of clinical remission. Of the 46 patients, 13 were ICA negative (group A). Among ICA\u2010positive patients, ICAs were &lt; 20 JDF units (group B) in 15, between 20 and 80 JDF in 9 (group C), and &gt; 80 JDF in 9 (group D). In group A, 9 patients had clinical remission for 7.5 \u00b1 1.7 months. Their basal C peptide level was 0.26 \u00b1 0.05 nmol\/L and it increased after stimulation to 44.5 \u00b1 2.5%. Ten patients in group B had remission for 6.2 \u00b1 1.5 months. Their basal C peptide levels (0.28 \u00b1 0.07 nmol\/L) were similarly increased after stimulation (47.5 \u00b1 2.5%). In group C, all patients had remission and it was of the longest duration (14.7 \u00b1 1.5 months). They had the highest basal C peptide levels (0.45 \u00b1 0.12 nmol\/L) with increases to 57.5 \u00b1 3.5%. Seven patients in group D with ICA levels &gt; 80 JDF had a short remission (3.2 \u00b1 1.2 months) despite good basal C peptide levels (0.42 \u00b1 0.05 nmol\/L) and excellent increases after stimulation (92.5%). Our results suggest that moderate levels of ICA are associated with good residual \u03b2 cell function and longer remission. Very high ICA levels (&gt; 80 JDF) at the time of diagnosis despite better \u03b2 cell function are associated with short clinical remission. Therefore, high ICA levels could be a marker of strong autoimmune reaction and accelerated depletion of \u03b2 cell function.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2002.tb02980.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T23:04:13Z","timestamp":1279667053000},"page":"251-253","source":"Crossref","is-referenced-by-count":9,"title":["Relation between Course of Disease in Type 1 Diabetes and Islet Cell Antibodies"],"prefix":"10.1111","volume":"958","author":[{"given":"M.","family":"ZAMAKLAR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"JOTIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"LALIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"LALIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"RAJKOVIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"MILICIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90140-8"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)91683-9"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00257781"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.1.45"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90013-U"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400345"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2002.tb02980.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2002.tb02980.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T22:56:46Z","timestamp":1695682606000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2002.tb02980.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["10.1111\/j.1749-6632.2002.tb02980.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb02980.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}